Drug application
PALONOSETRON HYDROCHLORIDE (PALONOSETRON HYDROCHLORIDE)
Drugs@FDA ANDA 206916 · BAXTER HLTHCARE CORP
Key facts
| Drug name | PALONOSETRON HYDROCHLORIDE |
|---|---|
| Active ingredients | PALONOSETRON HYDROCHLORIDE |
| Application type | ANDA |
| Application number | 206916 |
| Company | BAXTER HLTHCARE CORP |
| Dosage forms | INJECTABLE, INTRAVENOUS |
| Strength | EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) |
| Marketing status | Discontinued |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | Nov 12, 2021 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 10–99 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.